A detailed history of Bahl & Gaynor Inc transactions in Pfizer Inc stock. As of the latest transaction made, Bahl & Gaynor Inc holds 66,504 shares of PFE stock, worth $1.76 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
66,504
Previous 69,861 4.81%
Holding current value
$1.76 Million
Previous $1.95 Million 1.54%
% of portfolio
0.01%
Previous 0.01%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$27.7 - $31.39 $92,988 - $105,376
-3,357 Reduced 4.81%
66,504 $1.92 Million
Q2 2024

Aug 07, 2024

SELL
$25.26 - $29.6 $128,421 - $150,486
-5,084 Reduced 6.78%
69,861 $1.95 Million
Q1 2024

May 10, 2024

SELL
$25.89 - $29.73 $182,420 - $209,477
-7,046 Reduced 8.59%
74,945 $2.08 Million
Q4 2023

Feb 02, 2024

SELL
$26.13 - $33.94 $476,219 - $618,556
-18,225 Reduced 18.19%
81,991 $2.36 Million
Q3 2023

Nov 03, 2023

SELL
$32.09 - $37.51 $391,498 - $457,622
-12,200 Reduced 10.85%
100,216 $3.32 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $11,016 - $12,745
305 Added 0.27%
112,416 $4.12 Million
Q1 2023

May 03, 2023

SELL
$39.39 - $51.28 $348,010 - $453,058
-8,835 Reduced 7.3%
112,111 $4.57 Million
Q4 2022

Feb 10, 2023

SELL
$41.75 - $54.5 $182,739 - $238,546
-4,377 Reduced 3.49%
120,946 $6.2 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $85,900 - $104,863
1,963 Added 1.59%
125,323 $5.48 Million
Q2 2022

Aug 08, 2022

BUY
$46.53 - $55.17 $22,613 - $26,812
486 Added 0.4%
123,360 $6.47 Million
Q1 2022

May 12, 2022

SELL
$45.75 - $56.69 $18,574 - $23,016
-406 Reduced 0.33%
122,874 $6.36 Million
Q4 2021

Feb 10, 2022

SELL
$41.32 - $61.25 $21,403 - $31,727
-518 Reduced 0.42%
123,280 $7.28 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $265,133 - $340,587
-6,755 Reduced 5.17%
123,798 $5.33 Million
Q2 2021

Aug 06, 2021

SELL
$35.91 - $40.68 $138,684 - $157,106
-3,862 Reduced 2.87%
130,553 $5.11 Million
Q1 2021

May 11, 2021

SELL
$33.49 - $37.77 $18.6 Million - $20.9 Million
-554,640 Reduced 80.49%
134,415 $4.87 Million
Q4 2020

Feb 02, 2021

SELL
$33.47 - $42.56 $1.03 Million - $1.31 Million
-30,726 Reduced 4.27%
689,055 $25.4 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $401,193 - $470,691
-12,636 Reduced 1.73%
719,781 $26.4 Million
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $67.2 Million - $81.5 Million
-2,231,305 Reduced 75.29%
732,417 $24 Million
Q1 2020

May 26, 2020

BUY
$27.03 - $38.62 $52.3 Million - $74.7 Million
1,933,055 Added 187.55%
2,963,722 $96.7 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $67.5 Million - $96.5 Million
-2,498,157 Reduced 70.79%
1,030,667 $33.6 Million
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $39.5 Million - $44.8 Million
-1,200,465 Reduced 25.38%
3,528,824 $138 Million
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $12.3 Million - $16 Million
379,904 Added 8.73%
4,729,289 $170 Million
Q2 2019

Aug 12, 2019

BUY
$36.98 - $41.52 $40.3 Million - $45.2 Million
1,089,175 Added 33.41%
4,349,385 $188 Million
Q1 2019

May 13, 2019

BUY
$37.5 - $41.2 $4.56 Million - $5.01 Million
121,545 Added 3.87%
3,260,210 $138 Million
Q4 2018

Feb 12, 2019

BUY
$38.47 - $43.86 $43.5 Million - $49.5 Million
1,129,480 Added 56.22%
3,138,665 $137 Million
Q3 2018

Nov 09, 2018

SELL
$34.47 - $41.81 $36 Million - $43.7 Million
-1,044,456 Reduced 34.2%
2,009,185 $88.5 Million
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $7.55 Million - $8.05 Million
228,836 Added 8.1%
3,053,641 $111 Million
Q1 2018

May 11, 2018

SELL
$31.91 - $37.02 $8.86 Million - $10.3 Million
-277,523 Reduced 8.95%
2,824,805 $100 Million
Q4 2017

Feb 13, 2018

SELL
$33.26 - $35.29 $1.48 Million - $1.58 Million
-44,637 Reduced 1.42%
3,102,328 $112 Million
Q3 2017

Nov 13, 2017

SELL
$31.0 - $34.15 $11.6 Million - $12.8 Million
-375,196 Reduced 10.65%
3,146,965 $112 Million
Q2 2017

Aug 11, 2017

SELL
N/A
-149,592 Reduced 4.07%
3,522,161 $118 Million
Q2 2017

Aug 10, 2017

BUY
N/A
3,671,753
3,671,753 $119 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Bahl & Gaynor Inc Portfolio

Follow Bahl & Gaynor Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bahl & Gaynor Inc with notifications on news.